Gaius Therapeutics, Inc,

CIK 2132841 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gaius Therapeutics, Inc,.

Recent SEC filings

FiledFormAccession number
May 14, 2026D0002132841-26-000002